Irvine-based Edwards Lifesciences Corp. will receive more than $1 billion from rival Medtronic Inc. to settle a patent lawsuit.
The company and Minneapolis-based Medtronic were enmeshed for several years in litigation claiming that Medtronic’s CoreValve transcatheter replacement heart valve infringes upon Edwards’ patent for its Edwards Sapien transcatheter valve.
Medtronic said it would pay Edwards a one-time sum of $750 million and royalties of no less than $40 million yearly through April 2022.
Edwards and Medtronic also are dismissing all their legal matters and agreed not to sue each other over transcatheter heart valves for eight years.
―Vita Reed
